MetLife Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.9M | Sell |
493,565
-13,396
| -3% | -$781K | 0.15% | 97 |
|
|
2025
Q4 | $27.3M | Sell |
506,961
-16,675
| -3% | -$802K | 0.13% | 107 |
|
|
2025
Q3 | $23.6M | Sell |
523,636
-12,807
| -2% | -$598K | 0.11% | 136 |
|
|
2025
Q2 | $24.8M | Buy |
536,443
+9,375
| +2% | +$460K | 0.15% | 110 |
|
|
2025
Q1 | $32.1M | Sell |
527,068
-9,765
| -2% | -$569K | 0.17% | 91 |
|
|
2024
Q4 | $30.4M | Buy |
536,833
+9,631
| +2% | +$538K | 0.16% | 90 |
|
|
2024
Q3 | $27.3M | Sell |
527,202
-13,518
| -3% | -$634K | 0.16% | 101 |
|
|
2024
Q2 | $22.5M | Buy |
540,720
+64,251
| +13% | +$2.87M | 0.13% | 120 |
|
|
2024
Q1 | $25.8M | Sell |
476,469
-17,520
| -4% | -$892K | 0.17% | 98 |
|
|
2023
Q4 | $25.3M | Sell |
493,989
-23,014
| -4% | -$1.21M | 0.18% | 94 |
|
|
2023
Q3 | $30M | Sell |
517,003
-16,268
| -3% | -$997K | 0.23% | 67 |
|
|
2023
Q2 | $34.1M | Sell |
533,271
-15,524
| -3% | -$1.04M | 0.25% | 65 |
|
|
2023
Q1 | $38M | Sell |
548,795
-6,576
| -1% | -$464K | 0.27% | 58 |
|
|
2022
Q4 | $40M | Sell |
555,371
-11,312
| -2% | -$853K | 0.3% | 48 |
|
|
2022
Q3 | $40.3M | Sell |
566,683
-6,915
| -1% | -$502K | 0.34% | 43 |
|
|
2022
Q2 | $44.2M | Sell |
573,598
-19,529
| -3% | -$1.49M | 0.34% | 46 |
|
|
2022
Q1 | $43.3M | Buy |
593,127
+102,714
| +21% | +$6.9M | 0.28% | 57 |
|
|
2021
Q4 | $30.6M | Sell |
490,413
-11,475
| -2% | -$673K | 0.25% | 67 |
|
|
2021
Q3 | $29.7M | Sell |
501,888
-16,038
| -3% | -$1.06M | 0.27% | 66 |
|
|
2021
Q2 | $34.6M | Sell |
517,926
-15,978
| -3% | -$1.04M | 0.3% | 59 |
|
|
2021
Q1 | $33.7M | Sell |
533,904
-14,890
| -3% | -$926K | 0.31% | 59 |
|
|
2020
Q4 | $34M | Sell |
548,794
-22,677
| -4% | -$1.39M | 0.32% | 53 |
|
|
2020
Q3 | $34.5M | Sell |
571,471
-20,306
| -3% | -$1.22M | 0.38% | 48 |
|
|
2020
Q2 | $34.8M | Sell |
591,777
-12,467
| -2% | -$746K | 0.4% | 45 |
|
|
2020
Q1 | $33.7M | Sell |
604,244
-18,487
| -3% | -$1.13M | 0.46% | 37 |
|
|
2019
Q4 | $40M | Buy |
622,731
+177,579
| +40% | +$10.2M | 0.42% | 38 |
|
|
2019
Q3 | $22.6M | Sell |
445,152
-5,717
| -1% | -$269K | 0.25% | 72 |
|
|
2019
Q2 | $20.4M | Sell |
450,869
-13,242
| -3% | -$617K | 0.22% | 81 |
|
|
2019
Q1 | $22.1M | Sell |
464,111
-2,672
| -0.6% | -$133K | 0.24% | 76 |
|
|
2018
Q4 | $24.3M | Sell |
466,783
-7,944
| -2% | -$427K | 0.29% | 64 |
|
|
2018
Q3 | $29.5M | Sell |
474,727
-6,443
| -1% | -$382K | 0.3% | 62 |
|
|
2018
Q2 | $26.6M | Sell |
481,170
-10,138
| -2% | -$548K | 0.31% | 56 |
|
|
2018
Q1 | $31.1M | Sell |
491,308
-15,100
| -3% | -$971K | 0.37% | 48 |
|
|
2017
Q4 | $31M | Buy |
+506,408
| New | +$31.7M | 0.35% | 45 |
|
Other funds holding BMY
VCM
VPM
MetLife Investment Management's BMY Position: Q1 2026 in Review
MetLife Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 2.6% in Q1 2026, selling an estimated $781K and leaving 493,565 shares worth $29.9M. The position accounts for 0.15% of the portfolio, ranked #97.
MetLife Investment Management first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. The position peaked at $44.2M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- MetLife Investment Management held 493,565 shares of Bristol-Myers Squibb worth $29.9M as of Q1 2026.
- MetLife Investment Management sold 13,396 Bristol-Myers Squibb shares in Q1 2026, an estimated $781K.
- Bristol-Myers Squibb made up 0.15% of MetLife Investment Management's portfolio in Q1 2026, its #97 holding.
- MetLife Investment Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Bristol-Myers Squibb position peaked at $44.2M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.